🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to allow continued use of pasireotide in patie...
Status
Completed
Location
Ximed Research SC - SOM230B2412
Start Date
2013-06-10
Trial ID
NCT01794793
Treatments Being Tested
Somatostatin analogues are a last resort for medical intervention in hyperi...
Status
Completed
Location
University of Colorado Denver
Start Date
2017-03-22
Trial ID
NCT03103009
Treatments Being Tested
This study will evaluate long-term safety and tolerability of pasireotide L...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-05-18
Trial ID
NCT01590199
This study will assess the pharmacokinetic profile and the safety/tolerabil...
Status
Completed
Location
Cedars Sinai Medical Center SC - 4
Start Date
2006-06
Trial ID
NCT00446082
Treatments Being Tested
This study provided access to pasireotide sc in patients with Cushing's dis...
Status
Completed
Location
Advanced Research, LLC
Start Date
2011-08-16
Trial ID
NCT01582061
Treatments Being Tested
This study will estimate the treatment effect of everolimus in combination ...
Status
Terminated
Location
Dana Farber Cancer Institute SC-2
Start Date
2011-06
Trial ID
NCT01374451
Treatments Being Tested
The purpose of this randomized, multicenter, Phase III study was to compare...
Status
Completed
Location
Scottsdale Healthcare/TGen Clinical Research Service TGen Clinical Research Service
Start Date
2008-04
Trial ID
NCT00690430
Treatments Being Tested
There are no available medical treatment options for patients with non-func...
Status
Completed
Location
Endocrinology Section - Hospital Universitário Clementino Fraga Filho/Federal University of Rio de Janeiro
Start Date
2010-03
Trial ID
NCT01620138
Treatments Being Tested
The aim of NETTER-2 was to determine if Lutathera in combination with long-...
Status
Active Not Recruiting
Location
Yale Cancer Center
Start Date
2020-01-08
Trial ID
NCT03972488
To evaluate efficacy, safety, pharmacokinetics and pharmacodynamics of pasi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-10-16
Trial ID
NCT01673646
Treatments Being Tested